carcinoma-associated antigen 494

03/01/2000 - "In this study, the occurrence of CA 494 was characterized in colorectal cancer tissue and in patients' sera during metastatic disease. "
03/01/2000 - "Occurrence of carcinoma-associated antigen 494 in colorectal cancer tissue and in Patients' sera during metastatic disease."

03/01/2000 - "The correlation of CA 494 with CA 19-9 levels was lower (r = 0.532) than previously reported in pancreatic cancer."
03/12/1993 - "The sensitivity of pancreatic cancer was 90%, 44% and 90% for CA 19-9, CEA and CA 494, respectively. "
03/12/1993 - "In chronic pancreatitis, as the most important control population for pancreatic cancer, the specificity was 85%, 72% and 94% for CA 19-9, CEA and CA 494, respectively."
03/01/2000 - "CA 494 is a new carbohydrate epitope on a high-molecular-weight mucin-type glycoprotein which has been intensively investigated in pancreatic cancer. "
03/12/1993 - "In 59 patients with ductal pancreatic cancer the monoclonal antibody (MAb) BW 494, which detects the CA 494 glycoprotein antigen, was analyzed in comparison with the reference tumor markers CA 19-9 and CEA. "

03/12/1993 - "In chronic pancreatitis, as the most important control population for pancreatic cancer, the specificity was 85%, 72% and 94% for CA 19-9, CEA and CA 494, respectively."

03/01/2000 - "CA 494 was detected in cancer tissue from 82% of the 49 patients studied. "